After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries
ContributorsPombo-Suarez, Manuel ; Sanchez-Piedra, Carlos; Gómez-Reino, Juan; Lauper, Kim ; Mongin, Denis ; Iannone, Florenzo ; Pavelka, Karel; Nordström, Dan C; Inanc, Nevsun ; Codreanu, Catalin; Hyrich, Kimme L ; Choquette, Denis; Strangfeld, Anja ; Leeb, Burkhard F; Rotar, Ziga; Rodrigues, Ana; Kristianslund, Eirik Klami; Kvien, Tore K ; Elkayam, Ori; Lukina, Galina; Bergstra, Sytske Anne ; Finckh, Axel ; Courvoisier, Delphine
Published inAnnals of the rheumatic diseases
First online date2022-09-13
Abstract
Keywords
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Therapeutics
Affiliation entities
Research groups
Citation (ISO format)
POMBO-SUAREZ, Manuel et al. After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries. In: Annals of the rheumatic diseases, 2022. doi: 10.1136/ard-2022-222835
Main files (2)
Article (Accepted version)
Article (Published version)
Secondary files (2)
Identifiers
- PID : unige:164386
- DOI : 10.1136/ard-2022-222835
- PMID : 36100351
Commercial URLhttps://ard.bmj.com/lookup/doi/10.1136/ard-2022-222835
Journal ISSN0003-4967